Tarsier Pharma Ltd. (TARX)

Tarsier Pharma will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Tarsier Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	5.07	2.46
Depreciation & Amortization	0.01	0.01
Share-Based Compensation	1.29	0.6
Other Operating Activities	-7.69	-4.98
Operating Cash Flow	-1.32	-1.91
Capital Expenditures	-0	-0
Investing Cash Flow	-0	-0
Debt Issued / Paid	2.1	2.2
Financing Cash Flow	2.1	2.2
Net Cash Flow	0.78	0.29
Free Cash Flow	-1.32	-1.91

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).